4 - BRUE, Seizures, and Abnormal Movement: Evaluation and Management from the Subspecialists' Perspective.

Disclosure(s):

Joshua Bonkowsky, MD PhD: Autobahn: Research Support including clinical trials & the principal or named investigator (Ongoing); BioFire: Intellectual Property including patent beneficiary and royalties (Ongoing); Calico: Consultant (Terminated, October 21, 2021); European Leukodystrophy Association: Research Support including clinical trials & the principal or named investigator (Ongoing); Myrtelle: Consultant (Ongoing); Neurogene: Consultant (Terminated, March 1, 2022); NIH: Research Support including clinical trials & the principal or named investigator (Ongoing); Orchard: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); PassageBio: Research Support including clinical trials & the principal or named investigator (Ongoing); Sanofi: Contractor including contracted research (Ongoing); Shire/Takeda: Research Support including clinical trials & the principal or named investigator (Ongoing); SwanBio: Research Support including clinical trials & the principal or named investigator (Ongoing); wFluidx: Board Member or Executive Role (Ongoing)